Aider is a “pair-programming” tool that can use various providers as the AI back end, including a locally running instance of ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

Using ChatGPT is a lot simpler than you think, and there are many ways to make it work best for you. Amanda Smith is a freelance journalist and writer. She reports on culture, society, human interest ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Replimune Group ( (REPL)) has issued an ...

This is the online edition of The Wiretap newsletter, your weekly digest of cybersecurity, internet privacy and surveillance news. To get it in your inbox, subscribe here. ICE is using all manner of ...

The Hechinger Report covers one topic: education. Sign up for our newsletters to have stories delivered to your inbox. Consider becoming a member to support our nonprofit journalism. Writing can be ...

NEW YORK, Aug. 7, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. (NASDAQ: REPL). Shareholders who purchased shares of REPL during the ...